What Happened?
South San Francisco, BC-based Attralus Appointed Spencer Guthrie as Chief Executive Officer
About the Company
Amyloid diseases are a diverse group of disorders, characterized by the deposition of amyloid protein fibrils in vital organs and tissues. There are approximately 30 different types of amyloidosis, each resulting from the misfolding and aggregation of a specific protein, and they are all severely debilitating, progressive, and often fatal.
About the Person
Spencer Guthrie is Chief Executive Officer at Attralus. Previously, Spencer held various senior HR leadership roles in the industry.
Info Source
News
Short Profile